SCHEMBL6949437

SCHEMBL6949437

CSc1nc(NN)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 6/20 0.41
MAPT P10636 4/20 0.41
HTT P42858 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 2/20 0.41
TP53 P04637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RXFP1 Q9HBX9 3/20 0.38
THRB P10828 1/20 0.38
POLB P06746 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
GAA P10253 1/20 0.37
HIF1A Q16665 1/20 0.37
RAB9A P51151 1/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA13 Q8N1Q1 3/20 0.37
ADORA2A P29274 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949245 0.84 KDM4E (0.46) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6948665 0.84 KDM4E (0.48) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6956595 0.82 KMT2A (0.45) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6955347 0.80 LMNA (0.51) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL6951885 0.77 ALDH1A1 (0.46) KDM4EALDH1A1HTTKMT2AHPGD
SCHEMBL6949790 0.75 ALDH1A1 (0.41) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6947632 0.75 PIK3CD (0.39) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6953831 0.75 ALDH1A1 (0.46) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6429011 0.74 ALDH1A1 (0.41) KDM4EALDH1A1MAPTHTTMEN1
SCHEMBL6955735 0.74 ADRA2A (0.38) KDM4EALDH1A1MAPTHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed